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Abstract: As the Thoroughbreds race for the final stretch, 44 hooves flash and thunder creat-
ing a cacophony of tortured air and turf. Orchestrated by selective breeding for physiology and 
biomechanics, expressed as speed, the millennia-old symphony of man and beast reaches its 
climax. At nearly 73 kilometers per hour (45 mph) over half a ton of flesh and bone dwarfs 
its limpet-like jockey as, eyes wild and nostrils flaring, their necks stretch for glory. Beneath 
each resplendent livery-adorned, latherin-splattered coat hides a monstrous heart trilling at 4 
beats per second, and each minute, driving over 400 L (105 gallons) of oxygen-rich blood from 
lungs to muscles. Matching breath to stride frequency, those lungs will inhale 16 L (4 gallons) 
of air each stride moving >1,000 L/min in and out of each nostril – and yet failing. Engorged 
with blood and stretched to breaking point, those lungs can no longer redden the arterial blood 
but leave it dusky and cyanotic. Their exquisitely thin blood–gas barrier, a mere 10.5 μm thick 
(1/50,000 of an inch), ruptures, and red cells invade the lungs. After the race is won and lost, 
long after the frenetic crowd has quieted and gone, that blood will clog and inflame the airways. 
For a few horses, those who bleed extensively, it will overflow their lungs and spray from their 
nostrils incarnadining the walls of their stall: a horrifically poignant canvas that strikes at horse 
racing’s very core. That exercise-induced pulmonary hemorrhage (EIPH) occurs is a medical 
and physiological reality. That every reasonable exigency is not taken to reduce/prevent it would 
be a travesty. This review is not intended to provide an exhaustive coverage of EIPH for which 
the reader is referred to recent reviews, rather, after a brief reminder of its physiologic and 
pathologic bases, focus is brought on the latest developments in EIPH discovery as this informs 
state-of-the-art knowledge, the implementation of that knowledge and recommendations for 
future research and treatment.
Keywords: epistaxis, Thoroughbred racehorse, pulmonary capillary rupture, vascular pressure, 
alveolar pressure, nasal airway collapse
Background
Exercise-induced pulmonary hemorrhage (EIPH) is diagnosed most commonly in the 
racehorse,1–7 but also occurs in Greyhounds8 and healthy human athletes9 as well as 
in patients with diseases such as left heart failure which elevate pulmonary vascular 
pressures.5 Other human endeavors such as prolonged saxophone playing may also 
induce alveolar hemorrhage.10 In horses, the 2015 American College of Veterinary 
Internal Medicine Consensus Statement made the strong recommendation that EIPH 
be considered as a disease rather than a “condition”.7 The necessary conditions for 
EIPH in the healthy exercising horse consist of high pulmonary capillary transmural 
pressures, the product of a prodigious cardiac output, combined with very negative 
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alveolar pressures that summate across the exquisitely thin 
intervening blood–gas barrier. EIPH occurs primarily in 
Thoroughbreds, Quarter Horses and Standardbreds and 
during sprint racing. EIPH is also apparent across other 
high-performance equine athletes, including cutting, rein-
ing, barrel, roping, polo, cross-country and 3-day event, 
show jumping, hunter-jumper, steeplechase, dressage and 
draft horses.6,7,11 Indeed, even sustained submaximal exercise 
induces EIPH.12 EIPH is a substantial problem for the horse 
racing industry for multiple reasons that include decreased 
performance,6 lost training days, necessity for pre-race medi-
cation, banning of horses from racing, occasional death,13,14 
and public perception.1,6,15 Moreover, EIPH constitutes a criti-
cal basis for exercise intolerance and progressively damages 
a horse’s lungs in proportion to its lifetime starts and training 
history.1,16–19 Horses with either no or mild bleeding have a 
4-fold higher chance of winning a race as their counterparts 
with moderate or severe EIPH.6,15,19
Epistaxis, bleeding from the nostrils, is the most visible 
form of EIPH (Figure 1). This condition has been recog-
nized at least since Elizabethan times. For instance, Gervase 
Markham’s “Masterpiece” described bleeding after exercise 
in 1688,20–22 and elite racehorses certainly have epistaxis in 
their ancestry. For instance, Bartlett’s Childers was renamed 
from Bleeding Childers (b. 1716), and was the great Grand-
sire of the famous racehorse Eclipse (1764–1789), who 
never lost a race (Figure 2). Eclipse was so dominant that on 
 October 18, 1770, in the King’s Plate at Newmarket, his repu-
tation so scared other owners that they withdrew their horses, 
and he simply walked the course unopposed! He went on to 
sire 334 winners. This case report demonstrates that horses 
with severe EIPH/epistaxis (Bleeding Childers not Eclipse) 
can perform at the highest levels, despite the epidemiologi-
cal evidence that horses with the most severe EIPH do not 
perform as well as their less-affected counterparts.6,15,23–25 
It is also true that there are genetic (as well as nongenetic) 
links to EIPH/epistaxis.26 However, it is pertinent that such 
research is extremely challenging, and therefore, conclusions 
must be tempered with this reality in mind. There is also a 
rather controversial retrospective study reporting greater 
career longevity for horses with EIPH!27
Brief history of discoveries key to our 
understanding of eiPH
Understanding the pathogenesis of EIPH has necessitated 
substantial progress in pulmonary and cardiovascular anat-
omy and physiology, and it is instructive to follow key ele-
ments of that progress. Whereas Galen  (129 CE-c. 200/c.216) 
considered that most blood went through the lungs, he did 
hypothesize the existence of tiny pores through which blood 
passed from the right to the left ventricle.5 William Harvey 
(1578–1657) subsequently placed his “invisible porosities” 
within the lungs themselves and surmised that they were 
Figure 1 epistaxis, bleeding from the nostrils, is the most visible form of exercise-
induced pulmonary hemorrhage.
Note: Photograph courtesy of Professor M Roger Fedde.
Figure 2 The acclaimed racehorse eclipse, whose great Grandsire was Bleeding 
(Bartlett’s) Childers (1764–1789).
Note: Reproduced from Youatt w. The Horse. London: Longmans, Green, and Co.; 
1874.21
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actually small blood vessels.28 However, Harvey and his con-
temporaries considered the lungs to comprise solid material 
as for the liver. It was only in the early 1660s, with the use 
of hand lenses and very early compound microscopes, that 
Marcello Malpighi (1628–1694) simultaneously discovered 
the pulmonary capillaries and alveoli in the lungs of the living 
frog (Figure 3).29,30 Albert von Kölliker (1817–1905) in 1881 
first described the Type I and II pneumocytes5 that we now 
know constitute the “thin” portion of the blood–gas barrier for 
gas exchange and synthesize pulmonary surfactant essential 
for reducing surface tension and setting the extraordinary 
compliance of the lung, respectively. But it was only with the 
development of the electron microscope and its application 
to the pulmonary capillaries that Frank Low (1911–1998) 
visualized the exquisitely fine structure of the blood–gas 
barrier. His electron micrographs identified its tripartite 
structure consisting of the capillary endothelium, the alveolar 
epithelium and the intervening basement membrane with an 
in toto thickness of <0.5 μm in 2 seminal papers published 
in 1952 and 1953.31,32 Because gases diffuse far more slowly 
through fluids than air (>10–5) and exercise, especially in 
highly aerobic mammals such as the horse and dog, demands 
extremely high rates of oxygen and carbon dioxide transport 
across the blood–gas barrier, there has been strong selective 
pressure to ensure its thinness. It is worth remembering that 
the capacity for the lung to exchange oxygen and carbon 
dioxide is dependent upon the ratio of its functional surface 
area formed by Type I cells, some 2,800 m2 in the racehorse, 
to the thickness of the blood–gas barrier (~0.5 μm). To grasp 
the true enormity of this ratio, if we increased the blood–gas 
barrier thickness to 1 inch (ie, ×56,000) and did the same 
to the surface area, its 144 km2 would more than cover the 
world’s 5 smallest countries (San Marino, Tuvalu, Nauru, 
Monaco and Vatican City)!
Despite recognition of the thinness of the blood–gas barrier 
and the awareness that blood erupted into the alveolar space 
in diseases such as mitral stenosis which are characterized 
by high pulmonary vascular pressures,33,34 the source of the 
blood in EIPH was curiously attributed to the mucosa of the 
terminal bronchioles (ie, larger systemic circulation vessels). 
This situation persisted for 4 decades, and West considers 3 
reasons for this blind spot in understanding how the pulmonary 
capillaries can rupture:5 1) Misunderstanding of Laplace’s 
equation. Specifically, the capillary wall stress (S) is calculated 
as S = (P×r)/t, where P is transmural pressure, r is radius and 
t is wall thickness. As the strength of the blood–gas barrier 
comes from the 0.05 μm (ie, 50 nm) Type IV collagen of the 
basement membrane, S becomes very high despite r  being 
only 3–5 μm. 2) Lack of capillary rupture in other tissues. In 
stark contrast to the gas surrounding the pulmonary capillaries, 
their counterparts in muscle and other tissues are supported 
by the adjacent tissue matrix and also collagen struts35,36 such 
Figure 3 Left: Marcello Malpighi, professor of medicine and extraordinary anatomist and physiologist (1628–1694). Right: Malpighi’s depiction of the pulmonary capillaries and 
alveoli. i: 2 lungs with the alveoli on the left and the capillaries on the right. ii: pulmonary capillaries in the alveolus dissected open reveal the incredible density of capillaries 
that form the blood–gas barrier.
Note: Adapted from Malpighi M. De Pulmonibus [Lungs]. London: Philosophical Transactions of the Royal Society; 1661. Latin.29
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that their transmural pressures remain very low. They are thus 
not subject to catastrophic failure. 3) Lack of appreciation of 
elevated pulmonary artery pressures during exercise. Because 
the human pulmonary artery mean pressure at rest is low in 
comparison to the systemic (ie, ~15 versus ~93 mmHg), and 
it was not considered to be much elevated during exercise, 
high capillary transmural pressures were not suspected in 
healthy individuals. However, in 1986, Wagner et al measured 
elevated mean pulmonary artery and wedge pressures (estimate 
of venous and capillary pressures) in healthy humans during 
heavy but submaximal cycle ergometer exercise.37 Pulmonary 
artery pressure increased from 15 to 37 mmHg and wedge 
pressure from 14 to 21 mmHg demonstrating that pulmonary 
capillary pressures can become elevated during exercise.
In 1981, endoscopy revealed that ~70% of horses post-
race had significant blood in their airways,38 and subsequently 
hemosiderin-laden macrophages were recovered in tracheal 
washings from Thoroughbred horses in training.39 It is now 
recognized that the vast majority, if not all, performance 
horses experience EIPH (Figure 4),2,6 but fatalities attributed 
to EIPH are uncommon (Figure 5).
Thoroughbred horses have been bred for speed which has 
selected preferentially for a heart that can be up to 2% of their 
body mass compared with 0.5–1% for other mammalian spe-
cies.40 This has resulted in horses capable of generating cardiac 
outputs in excess of 400 L/min and achieving maximal oxygen 
uptakes well over 80 L/min – the highest measured to date in 
any species. To achieve these prodigious blood and oxygen 
fluxes, left ventricular filling pressures must be extraordinarily 
high and elevate pulmonary venous and capillary intraluminal 
pressures. In 1992, the first peer-reviewed paper was published 
demonstrating prodigiously high pulmonary artery pressures 
in horses during high-intensity treadmill running.41–44 These 
groundbreaking studies demonstrated that, simultaneously 
with mean systemic arterial pressures of 240 mmHg, mean 
pulmonary artery pressures reached ~120 mmHg, and directly 
measured left atrial pressure peaked at 70 mmHg. From such 
measurements, capillary intraluminal pressures in the region 
of 100 mmHg have been estimated (Figure 6).
The “other” side of the blood–gas barrier
Notwithstanding the extraordinary dimensions of racehorse 
lung surface area, the physical constraints of the chest wall 
have resulted in a structure that is underbuilt in comparison 
with the heart. In addition, the necessity for long extrathoracic 
airways (increasing dead space and airway(s) resistance) 
and the presence of collapsible nasal passageways provide 
additional impediments to pulmonary function.40,45,46 For an 
elite horse achieving 90 L/min oxygen uptake during the 
gallop with a 3 L dead space and a respiratory frequency of 
130 breaths per minute, controlling its arterial CO
2
 pressure 
at resting values of 40 mmHg would necessitate ~2,400 L/
min total ventilation. Whereas humans typically hyperven-
tilate driving arterial CO
2
 pressures down to 30 mmHg or so 
to help constrain the exercise-induced acidemia, the horse 
actually hypoventilates and allows its arterial CO
2
 to rise to 
~60 mmHg.42 Although this situation exacerbates the arte-
rial hypoxemia – the primary cause being the very short red 
blood cell (RBC) transit times in the pulmonary capillar-
ies – it  lowers the ventilatory demands of the exercise to an 
Figure 4 Blood in the trachea of a racehorse after maximal exercise as revealed 
by endoscopy.
Figure 5 Lungs excised from a horse with a rare fatal instance of exercise-induced 
pulmonary hemorrhage.
Note: Photograph courtesy of Dr Kurt J williams.
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achievable ~1,700 L/min. Even so, attaining the required peak 
flow rates approaching 120 L/min necessitates extremely low 
airway, and especially, alveolar negative pressures that may 
exceed –100 cmH
2
O. It is this negative pressure that sum-
mates with the positive intraluminal pressure across the thin 
blood–gas barrier rupturing it and causing EIPH.
The most compelling evidence that the pulmonary capil-
laries constitute the unequivocal site of EIPH includes the 
following:
 1.  Only microspheres (10 and 15 μm diameter, differ-
entially colored) injected into the jugular vein appear 
in the airways during a bout of EIPH. Those injected 
into the left atrium do not.43
 2.  There is irrefutable electron micrographic evidence for 
catastrophic pulmonary capillary rupture and RBCs 
escaping into the alveolar space in equids following 
heavy-/severe-intensity running (Figure 7).5,16,43
 3.  Although there are exceptions, as discussed in the 
“EIPH causes and mechanisms” section, the major-
ity of conditions that reduce the transmural pressure 
across the pulmonary capillary (eg, Lasix, nasal strip, 
correction of laryngeal hemiplegia) reduce EIPH, 
whereas elevation of capillary transmural pressures 
increases EIPH (eg, l-nitroarginine methyl ester 
[l-NAME] -induced pulmonary hypertension, inclined 
running, laryngeal hemiplegia/experimental increase 
of upper airway resistance).2,5
Consequently, the most effective approaches to reducing 
EIPH have focused on lowering either pulmonary capillary 
intraluminal pressures (furosemide/Lasix) or alveolar nega-
tive pressures (nasal strip, long-term management of airway 
health) as discussed in the “Prevention and treatment of 
EIPH” section.
Diagnosis and prevalence
epistaxis
Visible epistaxis, as seen in Figure 1, was the original 
method of diagnosing EIPH, and although considered to be 
a serious problem, its relatively rare occurrence (0.25–13% 
of all sprinting horses)47–49 mitigated concern. A compre-
hensive analysis of 250,000 race starts published in 2001 
reported the incidence of overt epistaxis to be only 0.15%.50 
That investigation and subsequent work (some using endos-
copy) noted that epistaxis/EIPH was most prevalent for the 
following:
Figure 6 Schematic depicting cross-section of a pulmonary capillary.
Notes: Alveolar negative and capillary luminal positive pressures summate across 
the perilously thin (0.5 μm total thickness, 50 nm basement membrane thickness) 
blood–gas barrier. Pressures shown are for maximal exercise in the horse.
Alveolar negative pressure
as high as –100 cmH2O
Luminal positive pressure
as high as 100 mmHg
Collagen
Alveolar lining layer
Alveolar epithelium
Basement membrane
Capillary endothelium
Figure 7 Left: Schematic showing exercise-induced pulmonary hemorrhage in the horse. Right: Scanning electron micrograph of the cranial lobe of an exercised pony reveals 
red blood cells (R) and proteinaceous material (P) in the alveoli. Bar =5 μm.
Notes: Left diagram courtesy of Flair, LLC by Brad Gilleland. Right figure adapted with permission from Erickson HH, McAvoy JL, Westfall JA. Exercise-induced changes in 
the lung of Shetland ponies: ultrastructure and morphometry. J Submicrosc Cytol Pathol. 1997;29(1):65–72.16
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 1.  shorter higher intensity races (greater pulmonary 
intravascular [positive] and extravascular [negative] 
pressures),
 2.  steeplechase compared with flat races (greater tidal 
volumes and respiratory/impact forces),50–52
 3.  older in preference to younger (~2-year olds) horses 
(more race starts),53
 4.  males rather than females (latter may retire earlier to 
breed),6 and
 5.  cool ambient temperatures.53,54
Bronchoalveolar lavage (BAL)
BAL when feasible is considered to provide the most sensitive 
determination of EIPH severity compared with tracheal lavage 
or endoscopy.55–59 Performed ideally 30 min post-race, the pro-
cedure consists of inserting either an endoscope or preferably 
a long, soft flexible tube into the naris which invariably wedges 
in a subsegmental bronchus subserving the dorsocaudal 
lobe.45,60 Then, 300 mL of phosphate-buffered saline (pH 7.4, 
300 mosm) is infused in 50 mL aliquots, and after 2 breaths, 
aspirated. Fluid recovery of ≥55% is acceptable, and that 
fluid is then analyzed for the cell populations of interest. BAL 
facilitates an accurate analysis of the cytological population in 
the terminal airways and alveolar spaces. Investigations using 
BAL indicate that hemorrhage occurs in almost all horses in 
racing or training,2,60,61 and BAL cytological findings cohere 
closely with clinical disease, pulmonary histopathology and 
endoscopic evidence of EIPH.57–60 Concerns regarding BAL 
most often include the need for rapid access to the horse post-
race, the need for sedation (eg, 10–20 μg/kg intravenous deto-
midine), whether the entire lung volume affected by EIPH is 
sampled and the potential for heterogeneity of EIPH between 
lungs.62 To date, many of the incisive investigations into the 
impact of furosemide, the nasal strip, immunomodulation and 
other therapeutic strategies on EIPH have successfully utilized 
BAL.1,3,45,55,59-61,63,65–73 By comparison, endoscopy (vide infra) 
evaluation is extremely crude (Figure 4)75 and also depends 
on transduction of blood into the trachea which may be a 
time- and posture-dependent process.
endoscopy
Use of a rigid endoscope enabled Cook in 1974 to recognize 
that the lungs, rather than extrathoracic airways or other 
putative sites, were the source of hemorrhage.47 Endoscopy 
increased the detection of post-race EIPH to up to over 
60% in Standardbreds,76,77 Quarter Horses78 and Thorough-
breds.49,79–82 Repeated examination of individual horses raised 
the detected incidence of EIPH to ~95%.78,80,81
Tracheal lavage
Whereas tracheal lavage can detect EIPH from the presence 
of hemosiderophages in the fluid aspirated, defining the 
time course of the hemorrhage is challenging. Moreover, 
the relationship between tracheal wash cytology and lung 
histopathology is weak.39,83,84 It is also concerning that the 
cell population in the tracheal fluid is markedly different from 
that in the lower respiratory tract.83,84
Radiography
EIPH is only vaguely discernible by radiography as an 
increase in interstitial density in the dorsocaudal lobe of the 
lung85–88 and is therefore of limited value. Potentially in horses 
with severe, repeated EIPH episodes, radiography may be of 
use in documenting EIPH progression.
echocardiography
Echocardiography may reveal a higher incidence of sponta-
neous contrast at rest in horses with a history of EIPH, but 
it is not quantitative.89–91
Nuclear scintigraphy
Small amounts of hemorrhage may potentially be detected 
with scintigraphy, but this is contingent upon the level of 
lung background radioactivity92 and results have generally 
been disappointing.2,85
There is no doubt that scientific progress into under-
standing EIPH mechanisms and treatment is dependent 
on evaluating bleeding severity acutely, as with BAL. But 
it is also true that assessment of the long-term impact of 
successive EIPH episodes will inform putative therapeutic 
strategies including race–race interval, immunomodulation, 
pre-race interventions, training regimens and possibly diet 
and breeding programs. Thus, development of an effective 
technique to assess pulmonary venous remodeling93,94 and 
the mechanical sequelae to repeated EIPH episodes in vivo 
would be extremely valuable.
EIPH causes and mechanisms
A variety of causes and pathophysiologic mechanisms have 
been postulated for EIPH. The experimental evidence indicates 
that a given instance of EIPH may be caused or exacerbated 
by multiple factors acting in concert.2 These can be grouped 
broadly into 3 primary categories that involve intravascular 
pressures (capillary, positive), extravascular pressures (alveo-
lar, negative) and properties of the blood–gas barrier (strength/
fragility) and lung parenchyma (reduced compliance/fibrosis).
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High pulmonary capillary intravascular 
pressures
Pulmonary artery pressure is set by the product of cardiac 
output and pulmonary vascular resistance. As mentioned 
 earlier, the immense heart size of the racehorse results in a 
huge stroke volume which, combined with maximal heart 
rates of ~240 beats per minute, results in extraordinary 
pulmonary blood flows. The pulmonary vascular resistance 
will in turn be set by the cross-sectional area of the resistance 
vessels and hemorheological properties (ie, apparent viscos-
ity) of the blood at a hematocrit of ≥65%. Thus, the driving 
pressure in the pulmonary artery will increase to achieve 
the required flow irrespective of downstream venous pres-
sures, and those pressures are elevated as the left ventricle 
becomes stiff (rate of relaxation is inadequate) requiring an 
elevated filling (left atrial) pressure. The pulmonary capil-
laries are thus caught between extremely high pulmonary 
artery pressures of ~120 mmHg and left atrial pressures 
that may rise to ≥70 mmHg such that mean pulmonary cap-
illary pressures of 100 mmHg are feasible (Figure 6). Two 
additional factors have been considered to also play a role 
in the elevated pulmonary vascular pressures: the resistance 
provided by the comparatively small cross-sectional area of 
the atrioventricular valves and regurgitation through these 
valves during ventricular systole when left ventricular pres-
sures may be ≥240 mmHg.40
Pulmonary blood flow in the equine lung is neither homo-
geneous nor distributed according to gravitational control.95 
Rather, arteriolar vasomotor control favors a preferential 
vasodilation toward the dorsal aspect of the lung such that 
blood flow increases from ventral–dorsal regions (ie, opposite 
to that expected from gravitational effects) and specifically is 
highest toward the dorsocaudal region that is most impacted 
by EIPH.95–99
Very high negative alveolar pressures
Generating peak inspiratory flow rates of ~120 L/s against 
the resistance provided by the horse’s long extrathoracic air-
ways demands a steep pressure gradient and hence extremely 
negative alveolar pressures (Figure 6).45,100,101 Anything that 
reduces airway(s) cross-sectional area will either compromise 
airflow or require an elevated driving pressure to maintain 
the same flow. Because the bulk of the pulmonary resistance 
especially during inspiration is located in the large extratho-
racic airways,88,101 upper airway obstruction, as caused by 
sucking in the soft tissue overlying the nasal passageways just 
rostral to the nasoincisive notch, profoundly increases airway 
resistance.1,70,100,102,103 This phenomenon requires even more 
negative alveolar pressures and is expected to exacerbate 
capillary rupture. Laryngeal hemiplegia, often identified as a 
pronounced roaring on inhalation, is also a cause of elevated 
large airway resistance and hence more negative alveolar 
pressures.104,105 Because the small airways constitute relatively 
little to total airways resistance owing to their far greater total 
(combined) cross-sectional area, their potential to increase 
total inspiratory resistance is far less. However, given its high 
prevalence,106 extensive small airways disease has certainly 
been considered as a potential contributing factor to EIPH, 
and even airway disease that is subclinical at rest may become 
important during maximal exercise. It is pertinent that there 
is a demonstrable association between lower airway disease 
and EIPH107,108 and also that experimentally induced inflam-
mation, consequent to instillation of dilute acetic acid into 
the distal bronchi, increases EIPH severity.109 Instillation of 
blood into the airways also causes a transient airway inflam-
mation that resolves within 2 weeks,110 but the fibrotic lesions 
characteristic of the lungs of horses with a prolonged history 
of EIPH may well require hemosiderin within the interstitial 
space.111 That not all horses with EIPH have any evidence of 
lower airway inflammation supports that this condition may 
exacerbate EIPH, but it by no means is a primary cause.6
Chronic lung damage
EIPH is associated with edema and blood in the alveolar 
space, small airways and interstitium. This produces airway 
irritation and inflammation, and with repeated strenuous 
exercise in either training or actual competition, the hem-
orrhage results in fibrosis/scarring, a weakened blood–gas 
barrier and sustained inflammation. The blood within 
the alveoli may adversely affect lung health and exercise 
capacity by interfering with gas exchange. Because chronic 
scarification changes the compliance properties of the lung 
and progresses as a “front” between 2 regions, diseased and 
healthy, there may be substantial shearing forces at the junc-
tion of these regions which increases capillary rupture and 
EIPH particularly upon forceful inhalation. There will also 
be the progression of veno-occlusive disease with repeated 
bouts of EIPH that further elevates pulmonary venous 
and capillary pressures. Specifically, repeated instances of 
hemosiderin accumulation, and possibly their inflammatory 
consequences, induce veno-occlusive remodeling of small-
diameter (100–200 μm) pulmonary veins primarily in the 
dorsocaudal region and fibrosis of the alveolar interstitium, 
bronchovascular bundle, septa and pleura.19,93,94,97–99,112 Both 
of these factors help explain how chronic EIPH worsens 
with repeated exercise and consequently increased age. An 
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important question is how much exercise and EIPH-induced 
damage is required to induce these changes. Certainly, it 
appears to be >2 weeks of intensive exercise training at least 
for the expected alterations in mRNA and protein expression 
which may be necessary precursors.6,94
Mechanical stresses of respiration and locomotion
Lung tissue is damaged by thoracic impact, and Schroter et 
al have suggested that the locomotory impact of the fore-
limbs produces a localized impulsive load on the chest wall 
sending pressure waves through the lung parenchyma.52,53,113 
These waves increase in magnitude, and therefore destructive 
potential, as the mass of affected tissue decreases toward the 
dorsocaudal lobe – the primary site of capillary rupture. For 
a 500 kg horse at the gallop, it is estimated that impulsive 
forces in excess of 100 kPa of 10 ms duration would be 
applied to the horses’ chest by each scapula which is expected 
to produce edema and hemorrhage. This elegant theory helps 
explain why horses that jump (steeplechase, eventing) gener-
ally experience greater EIPH than flat racers.2
Prevention and treatment of EIPH
Given the complex etiology of EIPH, it is not surprising that 
this condition has not been eradicated or that a unified treatment 
strategy has not been identified. Therapeutic countermeasures 
at best reduce but do not prevent EIPH and are aimed at either 
constraining the severity of EIPH or reducing the pernicious 
sequelae including inflammation and infection as well as pos-
sibly fibrosis and venous remodeling. Moreover, the issue is 
complicated by fact that the weight loss induced by the diuretic 
furosemide is a substantial performance enhancer as absolute 
V˙O
2
max is unaltered and the ~20 kg weight loss therefore 
increases mass-specific V˙O
2
max.114–117 The failure of investiga-
tions to quantify EIPH by BAL has also led to confusion, and 
in some instances, misdirection (eg, using endoscopy).75 Given 
the pressing and continued demand for effective prophylaxis 
and/or treatment to reduce EIPH, an extensive variety of phar-
macotherapeutic and management interventions have been 
developed. However, under scientific scrutiny, few of these have 
demonstrated efficacy in treating EIPH.1–3,6,118–120 Treatments 
proposed for EIPH are generally directed at or more than 1 of 
the putative causal mechanisms for EIPH considered earlier 
and include2,6 furosemide and other diuretics, dehydration, 
antihypertensive agents or pulmonary vasodilators that dilate 
the pulmonary vasculature (eg, nitric oxide [NO] inhalation, 
endothelin inhibition), drugs to decrease blood viscosity (eg, 
pentoxifylline), inhibition of platelet aggregation, transhexamic 
acid to inhibit fibrinolysis, nasal dilator strips to reduce the 
resistance and maintain full patency of the nasal passages, 
bronchodilators, surgical correction of laryngeal hemiplegia 
to decrease upper airway resistance, anti-inflammatory drugs/
strategies to reduce lower airway inflammation, hesperidin-
citrus bioflavinoids to reduce capillary fragility, aminocaproic 
acid and herbal remedies.2,6,68,118–120 Given that EIPH risk does 
not relate to any discernible combination of horse’s age, race 
distance/speed, air quality or track hardness,53 the following 
discourse focuses on interventions and treatments mentioned 
that either offer significant potential to treat EIPH and/or for 
which novel information is available.
Furosemide (Lasix, Salix, Frusemide)
Where permitted in North America, South America, Saudi 
Arabia and the Philippines,2,119 furosemide is the most 
commonly used race-day EIPH treatment.121–127 Typically 
administered 4 hours prior to racing, furosemide induces a 
vigorous diuresis and reduces EIPH (as assessed by BAL; 
Figure 8)68,69,127,128 by constraining the exercise-induced eleva-
tion of right atrial, pulmonary arterial, pulmonary wedge and 
pulmonary capillary pressures.42,68,69,129–132 There may also 
be a redistribution of pulmonary blood flow such that flow 
decreases to the “at-risk” dorsal lung regions.133 Specifically, 
Figure 8 The diuretic furosemide significantly (*) reduced exercise-induced pulmonary 
hemorrhage during high-intensity exercise as measured by bronchoalveolar lavage.
Notes: Vials upper left and right indicate, respectively, the appearance of BAL fluid 
from Control and Furosemide conditions. This effect is believed to be driven by the 
reduction in pulmonary blood flow and thus capillary intraluminal pressures. Adapted 
from Kindig CA, McDonough P, Fenton G, Poole DC, Erickson HH. Efficacy of nasal strip 
and furosemide in mitigating exercise-induced pulmonary hemorrhage in Thoroughbred 
horses. J Appl Physiol. 2001;91(3):1396–1400.68 
Abbreviations: eiPH, exercise-induced pulmonary hemorrhage; BAL, bronchoalveolar 
lavage.
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furosemide administered intravenously decreased EIPH by 
80–90% in Thoroughbred horses run to ~95% (1 mg/kg furo-
semide) and 120% (0.5 mg/kg furosemide) of their V˙O
2
max 
on the high-speed treadmill.68,69 Moreover, a systematic review 
and meta-analysis of 11 studies documented furosemide’s 
efficacy for reducing EIPH in over 5,000 Thoroughbred and 
Standardbred racehorses.24 There has been much consideration 
of furosemide’s vasodilatory effect on the smooth muscle of 
the pulmonary vasculature and bronchi. However, its pharma-
cokinetics is such that mean plasma levels will be in the very 
low ng/mL range 4 hours after administration of the regulation 
dose,134 and as such, these direct effects are highly unlikely.
Nasal dilators
Although external nasal dilator strips are of questionable 
efficacy for humans during exercise, at least where oral 
breathing is unobstructed, during exercise, horses are obligate 
nasal breathers. Accordingly, nasal resistance, and changes 
thereof, is of substantially greater importance to inspiratory 
mechanics and airflow in horses than humans. During forceful 
inhalations when galloping, partial collapse of the unsupported 
nasal passages occurs, and this increases airways resistance. 
Use of the FLAIR nasal strip to stabilize the nasal wall and 
prevent the partial airway collapse reduces intrapleural and 
alveolar pressure swings that contribute to capillary transmu-
ral pressures,100,103,135 thereby reducing EIPH by up to 50% as 
assessed by BAL (Figure 9).45,68,69,71 Moreover, those studies 
demonstrated that EIPH was reduced the most in those horses 
that were the heaviest bleeders on the control (no nasal strip) 
runs. Interestingly, during submaximal exercise, the nasal 
strip decreased V˙O
2
, consistent with the horse performing 
less respiratory muscle work. As humans can redistribute their 
cardiac output among locomotory and respiratory muscles dur-
ing maximal exercise,136 this raises the intriguing possibility 
that the nasal strip may enhance exercise performance if the 
blood flow (and O
2
) “spared” by the respiratory muscles was 
redistributed to the locomotory muscles. McDonough et al71 
demonstrated that, in the presence of a substantial EIPH reduc-
tion, performance was enhanced by wearing the nasal strip.
Support for nasal strips benefitting racehorses on the track 
has emerged from studies of 400 horses at the Calder Race 
Course in Florida across the 1999–2000 Thoroughbred season 
(Scollay M and Hernandez J, unpublished findings, 2000). 
Horses wearing the nasal strip achieved a 3.4% higher win per-
centage than their non-strip-wearing counterparts. Moreover, the 
nasal strip reduced the between-race interval from 29 to 23 days 
(p<0.05). Subsequently, 30 Thoroughbred racehorses at the 
Golden Gate Fields Racetrack in California, who were identified 
as having a history of severe EIPH, achieved a 65% decrease in 
BAL-assessed EIPH.72 These studies emphasize the importance 
of using BAL rather than endoscopy to quantify BAL.75
The FLAIR nasal strip has been broadly approved for 
use in flat- and harness-racing within North America; most 
notably, it was approved for California Chrome, the Triple 
Crown contender, at Belmont Park in 2014. The FLAIR strip 
has also been approved for use by all key non-racing regula-
tory bodies, including the Federation Equestrian International, 
the American Horse Shows Association, the National Reining 
Association, the United States Equestrian Team, the United 
States Polo Association, the National Barrel Horse Association, 
and the American Quarter Horse Association. In the interna-
tional market, the FLAIR strip has been approved for racing in 
the following countries: Mexico, Brazil, Trinidad, Barbados, 
Jamaica, the Netherlands, United Arab Emirates, Qatar, India, 
Australia (Harness), New Zealand, Korea and Singapore.
Whereas insufficient investigations have been performed 
to date on the nasal strip to conduct a meta-analysis, as for 
furosemide,24 the reduction in EIPH measured by BAL is 
substantial and robust enough to demonstrate statistical 
significance even with relatively small numbers of horses in 
each instance.45,68,69,71,72
Nitric oxide
NO is a vascular smooth muscle-relaxing factor that is pro-
duced endogenously via the action of NO synthase (NOS) 
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Figure 9 The nasal strip pictured at right significantly (*P<0.05) reduced exercise-
induced pulmonary hemorrhage during high-intensity exercise as measured by 
bronchoalveolar lavage.
Notes: Vials upper left and right indicate, respectively, the appearance of BAL fluid 
from Control and Nasal strip conditions. This effect is caused by the less negative 
alveolar pressures and thus reduced capillary transmural pressures. Adapted from 
Kindig CA, McDonough P, Fenton G, Poole DC, Erickson HH. Efficacy of nasal 
strip and furosemide in mitigating exercise-induced pulmonary hemorrhage in 
Thoroughbred horses. J Appl Physiol. 2001;91(3):1396–1400.68 
Abbreviations: eiPH, exercise-induced pulmonary hemorrhage; BAL, 
bronchoalveolar lavage.
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on l-arginine within vascular endothelial cells, muscles 
(preferentially Type II, fast twitch) and nervous tissues.137,138 
In addition, dietary nitrate can be reduced to nitrite by 
facultative bacteria in the mouth; upon resorption, circulat-
ing nitrate is further reduced, especially by deoxygenated 
hemoglobin to NO.139 Inhibition of NOS using the l-arginine 
analog l-NAME increases pulmonary artery pressure and 
EIPH in maximally exercising horses140–142 suggesting a 
key role for NO in mediating endothelial function during 
exercise. Whereas nitroglycerin forms NO and is a potent 
vasodilator, neither intravenous nor oral dosing reduces 
exercise-induced hypertension in the exercising horse.143,144 
The same is true for the phosphodiesterase inhibitor silde-
nafil.145 In contrast, whereas inhalation of 80 ppm NO 
reduces pulmonary artery pressure in horses during heavy-/
severe-intensity exercise, it simultaneously increases EIPH 
as assessed by BAL (Figure 10).146–148 This dissociation of 
pulmonary artery pressure and EIPH by NO inhalation has 
revealed that pulmonary hypertension may, in part, be the 
consequence of downstream arteriolar vasoconstriction that 
actually protects the fragile dorsocaudal capillaries from high 
blood flows and associated pressures. Although NO lowers 
pulmonary artery pressure, it prevents this protective effect, 
and EIPH is actually worsened.148 This conclusion, regarding 
the effect of high pulmonary artery pressures being protective 
in certain instances, is also  supported by the elevated EIPH 
seen  concomitant with reduced pulmonary artery pressures 
during inclined running.66
Concentrated equine serum
Because EIPH may be potentiated by inflammatory airway 
disease60,107,149 and EIPH severity is associated with increased 
IL-6 expression,150 strategies to reduce post-EIPH parenchy-
mal tissue damage and subsequent scarring may be valuable. 
The concentrated equine serum (CES) Seramune® contains 
high levels of equine IgG and other immunoglobulins col-
lected from draft horse donors. Following field studies that 
supported its potential therapeutic benefit to treat chronic 
EIPH sufferers and safety assessment, a dosage of 20 mL 
intratracheally and 10 mL intravenously was administered 
for 5 consecutive days with a booster dose weekly and 
24–48 hours before heavy treadmill running. This treatment 
regimen was completed at different racetracks over a 5-year 
period and demonstrated a reduction in EIPH and mucus. 
This CES treatment reduced EIPH by 53% and white blood 
cells by 32% as assessed by BAL (Figure 11).120,151,152
Omega-3 fatty acids
Equine supplements often contain omega-3 fatty acids, and 
their capacity to impede the arachadonic acid cascade and 
thus airway inflammation has been hypothesized to decrease 
EIPH. Moreover, diets rich in docasahexaenoic acid (DHA) 
and eicosapentaenoic acid (EPA) may also constrain the 
Figure 10 inhaled nitric oxide (80 ppm) lowered pulmonary vascular pressures 
substantially but significantly increased exercise-induced pulmonary hemorrhage as 
measured by bronchoalveolar lavage.
Notes: This demonstrates that some degree of pulmonary vasoconstriction is 
actually protecting the fragile pulmonary capillaries under control conditions. 
*P<0.05. Adapted from Kindig CA, McDonough P, Finley MR, et al. NO inhalation 
reduces pulmonary arterial pressure but not hemorrhage in maximally exercising
horses. J Appl Physiol (1985). 2001;91(6):2674–2678.148 
Abbreviations: eiPH, exercise-induced pulmonary hemorrhage; BAL, 
bronchoalveolar lavage.
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Figure 11 Concentrated equine serum decreased exercise-induced pulmonary 
hemorrhage during high-intensity exercise as measured by bronchoalveolar lavage.
Notes: *P<0.05. Data from epp et al.151 
Abbreviations: eiPH, exercise-induced pulmonary hemorrhage; BAL, 
bronchoalveolar lavage.
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reduction in erythrocyte membrane fluidity during exercise 
and improve pulmonary hemodynamics reducing EIPH.153 
This hypothesis was supported at Kansas State University 
where 10 Thoroughbred horses fed a DHA- and EPA-enriched 
diet for 83 and 145 days evidenced a decreased EIPH.67
Herbal formulations
A variety of herbal formulations that claim to “clear heat and 
edema from the lung, cool and nourish the blood, and move 
stagnated blood out of the airways”154,155 have been used to 
treat EIPH in horses. Some herbal formulations have also 
been designed to treat impaired coagulation and modify 
platelet function, both of which have been considered to con-
tribute to EIPH. Within our laboratory, we find no evidence 
that Yunnan Paiyao and Single Immortal have efficacy for 
reducing EIPH in Thoroughbred racehorses.73
Conjugated estrogens and 
antifibrinolytics
Despite the absence of scientific evidence for increased fibri-
nolysis or impaired coagulation in horses with EIPH,156–158 use 
of conjugated estrogens and antifibrinolytics is widespread in 
the racing industry. Aminocaproic acid at 30 and 100 mg/kg 
(intravenous) doses in resting horses has an antifibrinolytic 
effect.159 Whereas both of these treatments, conjugated estro-
gens and aminocaproic acid, tended to decrease EIPH after 
severe-intensity treadmill, there was evidence for compro-
mised running performance after aminocaproic acid.67,160,161 
The potential of conjugated estrogens to decrease EIPH in 
some horses along with enhancing performance indicates the 
need for broader mechanistic investigation.
Conclusion
EIPH occurs in essentially all performance horses evaluated 
by BAL where, although rarely fatal, greater severity of bleed-
ing has been associated with poor performance6 and may 
curtail racing longevity. EIPH becomes worse with advanc-
ing age most likely because older horses have more racing 
history and lifetime starts and therefore more structural and 
functional (mal)adaptations of the lungs. EIPH results from 
catastrophic mechanically induced rupture of the exquisitely 
thin blood–gas barrier that interposes between the pulmonary 
capillary blood and alveolar gas with the dorsocaudal regions 
of the lung most heavily impacted (Figure 7). Whereas the 
mechanistic bases for EIPH are complex, they summate as 
the effective capillary transmural pressure and the strength 
or integrity of the intervening blood–gas barrier (Figure 6). 
As such, anything that increases the positive capillary 
 intravascular pressures or the negative alveolar pressures 
will exacerbate EIPH as will scarification or weakness of the 
barrier itself. Because the performance horse must achieve 
magnificently high cardiac outputs during maximal exercise, 
intravascular pressures reach levels normally associated with 
the systemic circulation (ie, 100 mmHg).45,46  Just 0.5 μm 
away, the alveolar pressure must be extremely negative to 
draw air into the lungs at peak flow rates of ≥120 L/s against 
an airways resistance that is accentuated by long extrathoracic 
airways, partial collapse of the nasal passages and possibly 
inflammatory compromise of small airway patency. In horses, 
pulmonary capillary (and presumably capillary transmural) 
pressures >~90 mmHg in vitro48 and in vivo50 rupture the 
blood–gas barrier which heals rapidly after the pulmonary 
capillary hypertension is relieved.162 However, parenchymal 
damage and associated inflammatory processes combined 
with RBCs remaining in the lung interstitium drive structural 
and mechanical changes that not only compromise barrier 
strength and integrity but also elevate pulmonary vascular 
pressures during subsequent exercise bouts (ie, veno-occlu-
sive disease).19,93,94,97–99,112
Recently, it has become evident that high pulmonary 
artery pressures may reflect a selective vasoconstriction 
within the pulmonary arterioles that actually serve to protect 
capillaries within the dorsocaudal lung regions that would 
otherwise rupture. Thus, conditions such as inclined running 
and 80 ppm NO inhalation that lowers pulmonary artery pres-
sures exacerbate EIPH severity.2,66,148 In this regard, it would 
be extremely valuable to define the role played by different 
segments of the pulmonary vasculature in EIPH, especially 
as this relates to their structure and vasomotor control, and 
potentially, changes thereof with repeated EIPH episodes 
within and across racing seasons. In this regard, the studies 
of Stack et al particularly on the pulmonary venules and veins 
may prove to be extremely insightful.93,94,96–99
In terms of therapeutic countermeasures that have sci-
entifically proven efficacy in reducing but not abolishing 
EIPH, furosemide is by far the most widely used (Figure 8). 
Given the likelihood that furosemide will be banned in North 
America as a race-day drug in the near future, there is an 
urgent need for an effective alternative. At present, perhaps, 
the best candidate for race-day alleviation of EIPH is the 
nasal strip (Figure 9), use of which is gaining in popular-
ity. Resistance to use of the nasal strip as an alternative to 
furosemide in the racing industry has likely resulted from the 
overarching fact that, without the ~20 kg weight loss from 
furosemide-induced diuresis, nasal strips (or other counter-
measures) do not increase performance sufficiently, or at least 
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not to the extent that furosemide does. At present, there is 
a pressing need for large-scale field trials of the nasal strip 
ideally using BAL to measure reductions in EIPH severity. 
In addition, given the hopeful (albeit small scale) results of 
immunomodulation therapy and conjugated estrogens these 
putative therapeutic avenues are deserving of closer scientific 
scrutiny (Figure 11). Resolution of therapeutic efficacy is, to 
a great extent, contingent on an accurate and sensitive method 
to quantify EIPH. At present, the more invasive but sensitive 
BAL is far better than endoscopy but more challenging to 
build into field studies. However, in the absence of a better 
method, effective progress in EIPH reduction/prevention 
may be contingent on wider use of BAL in the field. For 
EIPH mitigation, strategies incorporating longer race–race 
intervals, investigating dehydration strategies (to mimic the 
plasma volume/weight loss and lower pulmonary vascular 
pressures of furosemide), and in the longer term, selective 
breeding programs based upon deselecting for EIPH26 are 
worthy of serious consideration and investigation.
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